Definitive Healthcare Proxy: Executive Pay Details Released
Ticker: DH · Form: DEF 14A · Filed: Apr 23, 2025 · CIK: 1861795
| Field | Detail |
|---|---|
| Company | Definitive Healthcare Corp. (DH) |
| Form Type | DEF 14A |
| Filed Date | Apr 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, governance
Related Tickers: DFIN
TL;DR
Definitive Healthcare's proxy statement is out, showing exec pay details for 2024. Check equity awards for Musslewhite & Krantz.
AI Summary
Definitive Healthcare Corp. filed its DEF 14A on April 23, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted to key personnel such as Musslewhite and Krantz, with reported values as of the end of the fiscal year.
Why It Matters
This filing provides shareholders with crucial information regarding how executive compensation is structured and awarded, impacting corporate governance and investor confidence.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures, but can sometimes reveal compensation practices that may be viewed unfavorably by investors, impacting stock price.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for executive compensation)
- 20250423 — Filing Date (Date the DEF 14A was submitted to the SEC)
Key Players & Entities
- Definitive Healthcare Corp. (company) — Filer of the DEF 14A
- Musslewhite (person) — Executive mentioned in compensation details
- Krantz (person) — Executive mentioned in compensation details
- 0000950170-25-057364 (dollar_amount) — Accession number for the filing
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with detailed information about the company's executive compensation, director compensation, and other corporate governance matters, as required by the SEC.
Who are the key executives whose compensation details are highlighted?
The filing specifically mentions executives such as Musslewhite and Krantz in the context of equity awards and their fair value calculations.
What fiscal year does this filing primarily cover regarding compensation?
This filing primarily covers the fiscal year ending December 31, 2024, detailing compensation and equity awards for that period.
What is the filing date of this DEF 14A?
This DEF 14A filing was made on April 23, 2025.
What type of awards are detailed in the filing for the fiscal year 2024?
The filing details equity awards, including their fair value as of the vesting date of prior year awards vested in the covered year, and year-end fair value of equity awards granted in the covered year outstanding and unvested.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 23, 2025 by Musslewhite regarding Definitive Healthcare Corp. (DH).